NCT02058420View on ClinicalTrials.gov

Tocotrienols and Bone Health of Postmenopausal Women

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2022

Conditions
Osteoporosis
Interventions
DRUG

Low tocotrienols group

300 mg tocotrienols daily

DRUG

High tocotrienols group

600 mg tocotrienols daily

Trial Locations (1)

79430

Texas Tech University Health Sciences Center, Lubbock

All Listed Sponsors
collaborator

Texas Woman's University

OTHER

lead

Texas Tech University Health Sciences Center

OTHER

NCT02058420 - Tocotrienols and Bone Health of Postmenopausal Women | Biotech Hunter | Biotech Hunter